Evidence map›Paper›PMID 42589814›Full record

ArticlePolymers2026

Wound Healing Efficacy of Novel Dermal Substitute TissueDerm Graft

Kyu-Sik Shim, Dohyun Kim, Jeongwoo Park, Han-Saem Jo, Nayeon Koo, Won Jai Lee, Tai Suk Roh, Wooyeol Baek

Abstract read
In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kyu-Sik ShimPLCOskin Co., Ltd., Seoul 03721, Republic of Korea.
Dohyun KimPLCOskin Co., Ltd., Seoul 03721, Republic of Korea.ORCID 0009-0003-5530-2161
Jeongwoo ParkPLCOskin Co., Ltd., Seoul 03721, Republic of Korea.
Han-Saem JoPLCOskin Co., Ltd., Seoul 03721, Republic of Korea.
Nayeon KooPLCOskin Co., Ltd., Seoul 03721, Republic of Korea.
Won Jai LeeDepartment of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Tai Suk RohDepartment of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.ORCID 0000-0001-8681-159X
Wooyeol BaekPLCOskin Co., Ltd., Seoul 03721, Republic of Korea.ORCID 0000-0002-6638-4110

Funding

Korea/ Israel Industrial Research and Development Foundation Project No. 2022-42-196Ministry of SMEs and Startups RS-2023-00302877Ministry of Trade, Industry and Energy RS-2024-00433253
6 · The paper itself

Abstract

Autologous skin grafting is considered the standard treatment for full-thickness skin defects and provides essential dermal reconstruction to support both functional and aesthetic skin outcomes. However, it has limitations, such as increased donor-site morbidity, suboptimal aesthetic outcomes, thickness mismatches, texture irregularities, and scar contractions. Several dermal substitutes have been developed to overcome these limitations. In the present study, we introduce TissueDerm Graft

Indexed as

collagenfull-thickness skin defectskin graftingskin tissue regenerationwound healing

Identifiers

PMID42589814
PMCPMC13468572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.